Australia's EchoIQ soars to near 15-year high after Pro Medicus deal

Pro Medicus

25/06/2026 04:22

** EchoIQ's shares EIQ.AX gain as much as 51.2% to A$1.875, their highest level since August 3, 2011
** Medtech firm says it signed an agreement with health imaging firm Pro Medicus PME.AX for strategic investment and U.S. commercial partnership
** PME to invest an initial A$10 million ($6.89 million), with an option to invest further A$10 million following U.S. FDA clearance of EchoSolv HF, an AI-driven clinical decision support software - co
** PME to become a proposed reseller of EchoSolv, subject to entry into definitive agreements - EIQ
** Around 11.3 mln shares traded so far, nearly 4.6x 30-day average
** EIQ up more than 500% YTD
($1 = 1.4507 Australian dollars)

(Reporting by Keshav Singh Chundawat in Bengaluru)
((Keshav.singhchundawat@thomsonreuters.com))